BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Greene CM, Varley RB, Lawless MW. MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled. World J Gastroenterol 2013; 19(32): 5212-5226 [PMID: 23983424 DOI: 10.3748/wjg.v19.i32.5212]
URL: https://www.wjgnet.com/1948-5182/full/v19/i32/5212.htm
Number Citing Articles
1
Zheng Lou, Yong‑Qiang Gong, Xing Zhou, Guo‑Huang Hu. Low expression of miR‑199 in hepatocellular carcinoma contributes to tumor cell hyper‑proliferation by negatively suppressing XBP1Oncology Letters 2018;  doi: 10.3892/ol.2018.9476
2
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3029 doi: 10.1007/978-3-319-26956-6_168
3
Guy Rostoker, Nosratola D. Vaziri. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for cautionHemodialysis International 2017; 21(S1) doi: 10.1111/hdi.12557
4
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_168-1
5
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 83 doi: 10.1016/B978-0-323-98807-0.00003-X
6
Michael C. Kew. Hepatic Iron Overload and Hepatocellular CarcinomaLiver Cancer 2014; 3(1): 31 doi: 10.1159/000343856
7
Hongyu Zhang, Hongxia Liang, Shuhuan Wu, Yingying Zhang, Zujiang Yu. MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2)Environmental Toxicology and Pharmacology 2021; 82: 103559 doi: 10.1016/j.etap.2020.103559
8
Chan Shan, Yan Liang, Kun Wang, Peifeng Li. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunityBiomedicine & Pharmacotherapy 2023; 165: 115053 doi: 10.1016/j.biopha.2023.115053
9
Tong-Jiang Xu, Peng Qiu, Yu-Bao Zhang, Sheng-Yuan Yu, Guang-Ming Xu, Wei Yang. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9Human Cell 2019; 32(4): 548 doi: 10.1007/s13577-019-00279-9
10
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive reviewWorld Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
11
Ling Yin, Geoffrey D. Keeler, Yuanhui Zhang, Brad E. Hoffman, Chen Ling, Keyun Qing, Arun Srivastava. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivoGene Therapy 2021; 28(7-8): 422 doi: 10.1038/s41434-020-0140-1
12
Tomer Adar, Yaron Ilan, Deborah Elstein, Ari Zimran. Liver involvement in Gaucher disease – Review and clinical approachBlood Cells, Molecules, and Diseases 2018; 68: 66 doi: 10.1016/j.bcmd.2016.10.001
13
Xiao-Ying Chen, Yao-Xing Dou, Dan-Dan Luo, Zhen-Biao Zhang, Cai-Lan Li, Hui-Fang Zeng, Zi-Ren Su, Jian-Hui Xie, Xiao-Ping Lai, Yu-Cui Li. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathwaysInternational Immunopharmacology 2017; 50: 270 doi: 10.1016/j.intimp.2017.07.001
14
Pierre Lelièvre, Lucie Sancey, Jean-Luc Coll, Aurélien Deniaud, Benoit Busser. Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for TherapyCancers 2020; 12(12): 3524 doi: 10.3390/cancers12123524
15
Huiqing Wang, Xiaoyu Shi, Shanbin Wu. miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT processMolecular and Cellular Biochemistry 2020; 472(1-2): 115 doi: 10.1007/s11010-020-03790-y
16
Yichao Zhao, Chaoqian Zhu, Qing Chang, Peng Peng, Jie Yang, Chunmei Liu, Yang Liu, Xiaonan Chen, Yuanguang Liu, Ran Cheng, Yijie Wu, Xiaotang Wu, Liang Hu, Jun Yin, Klaus Roemer. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7PLOS ONE 2020; 15(11): e0242179 doi: 10.1371/journal.pone.0242179
17
Abolfazl Akbari, Hassan Mehrad Majd, Reyhane Rahnama, Javad Heshmati, Mojgan Morvaridzadeh, Shahram Agah, Seyed Mohammad Amini, Mohsen Masoodi. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancersBiomedicine & Pharmacotherapy 2020; 131: 110729 doi: 10.1016/j.biopha.2020.110729
18
Jing Chen, Kai Zhang, Yuejuan Xu, Yanping Gao, Chen Li, Rui Wang, Longbang Chen. The role of microRNA-26a in human cancer progression and clinical applicationTumor Biology 2016; 37(6): 7095 doi: 10.1007/s13277-016-5017-y
19
Nashwa El-Khazragy, Safa Matbouly, Demiana H. Hanna, Nievin Ahmed Mahran, Sally Abdallah Mostafa, Bassam A. Abdelrehim, Yasmeen K. Farouk, Soha Abuelela. Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guideAnnals of Hematology 2021; 100(12): 2909 doi: 10.1007/s00277-021-04639-0
20
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 109 doi: 10.1016/B978-0-323-98806-3.00007-6
21
Xuefei Zhang, Lingling Wang, Haixia Li, Lei Zhang, Xiulan Zheng, Wen Cheng. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progressionCell Death & Disease 2020; 11(7) doi: 10.1038/s41419-020-02772-8
22
Yukio Osaki, Hiroki Nishikawa. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work reviewHepatology Research 2015; 45(1): 59 doi: 10.1111/hepr.12378
23
Jun Zhao, Matthew W. Lawless. MicroRNAs and Other Non-Coding RNAs in Inflammation2015; : 219 doi: 10.1007/978-3-319-13689-9_12
24
Siqi Zhao, Wubin Zheng, Chao Yu, Gaoxin Xu, Xinyi Zhang, Chao Pan, Yongheng Feng, Kunxing Yang, Jin Zhou, Yong Ma. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.845232
25
Yu Liu, Guangyan Li, Fayu Lu, Ziwei Guo, Shuang Cai, Taoguang Huo. Excess iron intake induced liver injury: The role of gut-liver axis and therapeutic potentialBiomedicine & Pharmacotherapy 2023; 168: 115728 doi: 10.1016/j.biopha.2023.115728
26
Shane O’Grady, Matthew W. Lawless. Epigenetic Cancer Therapy2015; : 269 doi: 10.1016/B978-0-12-800206-3.00012-4
27
Fangfang Guo, Xiaotang Yang, Chengxiang Hu, Wannan Li, Weiwei Han. Network Pharmacology Combined with Machine Learning to Reveal the Action Mechanism of Licochalcone Intervention in Liver CancerInternational Journal of Molecular Sciences 2023; 24(21): 15935 doi: 10.3390/ijms242115935
28
Wujun Chen, Xiaolin Wu, Jianxia Hu, Xiaolei Liu, Zhu Guo, Jianfeng Wu, Yingchun Shao, Minglu Hao, Shuangshuang Zhang, Weichao Hu, Yanhong Wang, Miao Zhang, Meng Zhu, Chao Wang, Yudong Wu, Jie Wang, Dongming Xing. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02119-z
29
Yan Wang. The inhibition of microRNA-15a suppresses hepatitis B virus-associated liver cancer cell growth through the Smad/TGF-β pathwayOncology Reports 2017; 37(6): 3520 doi: 10.3892/or.2017.5618
30
Jinghan Li, Simeng Wang, Jiaqi Duan, Peixin Le, Chao Li, Yongpei Ding, Rui Wang, Yonggang Gao. The protective mechanism of resveratrol against hepatic injury induced by iron overload in miceToxicology and Applied Pharmacology 2021; 424: 115596 doi: 10.1016/j.taap.2021.115596
31
Jessye Wojtusik, Erin Curry, Terri L. Roth. Rhinoceros Serum microRNAs: Identification, Characterization, and Evaluation of Potential Iron Overload BiomarkersFrontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.711576
32
Ayman Yosry, Naglaa Zayed, Reham M Dawood, Marwa K Ibrahim, Marwa Elsharkawy, Sherif M Ekladious, Ahmed Khairy, Aisha Elsharkawy, Marwa Khairy, Shereen Abdel Alem, Noha G Bader El Din, Mostafa K El Awady, Zeinab Abdellatif. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCCLaboratory Medicine 2022; 53(5): 523 doi: 10.1093/labmed/lmac045
33
Jun Zhao, Matthew W. Lawless. Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancerCytokine 2013; 64(3): 626 doi: 10.1016/j.cyto.2013.09.009
34
Jun Zhao, Matthew W. Lawless. Long noncoding RNAs and their role in the liver cancer axisNature Reviews Gastroenterology & Hepatology 2013; 10(12): 703 doi: 10.1038/nrgastro.2013.87-c1
35
Anna Emilia Kern, Gregor Ortmayr, Alice Assinger, Patrick Starlinger. The role of microRNAs in the different phases of liver regenerationExpert Review of Gastroenterology & Hepatology 2023; 17(10): 959 doi: 10.1080/17474124.2023.2267422
36
Jianxing Zheng, Daming Cheng, Dongyang Wu, Libing Wang, Fengzhi Qu, Xiaotang Wu, Ling Cheng, Yanbin Wei, Xiaogang Liu. MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular carcinoma cells via targeting COLEC10Personalized Medicine 2021; 18(2): 97 doi: 10.2217/pme-2020-0027
37
Liang Liang, Jiang-hui Zeng, Jie-yu Wang, Rong-quan He, Jie Ma, Gang Chen, Xiao-yong Cai, Xiao-hua Hu. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics studyPathology - Research and Practice 2017; 213(12): 1494 doi: 10.1016/j.prp.2017.10.001
38
Juliane Liese, Jan Peveling-Oberhag, Claudia Doering, Andreas A. Schnitzbauer, Eva Herrmann, Stephan Zangos, Martin L. Hansmann, Christian Moench, Martin W. Welker, Stefan Zeuzem, Wolf O. Bechstein, Frank Ulrich. A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantationTransplant International 2016; 29(3): 369 doi: 10.1111/tri.12733
39
Jun Zhao, Catherine M Greene, Steven G Gray, Matthew W Lawless. Long noncoding RNAs in liver cancer: what we know in 2014Expert Opinion on Therapeutic Targets 2014; 18(10): 1207 doi: 10.1517/14728222.2014.941285
40
Amar Mahgoub, Clifford Steer. MicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesJournal of Clinical Medicine 2016; 5(5): 52 doi: 10.3390/jcm5050052
41
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinomaMolecular Biology Reports 2020; 47(10): 7429 doi: 10.1007/s11033-020-05798-5
42
Reza Mahmoudi-Lamouki, Sepideh Kadkhoda, Bashdar Mahmud Hussen, Soudeh Ghafouri-Fard. Emerging role of miRNAs in the regulation of ferroptosisFrontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1115996
43
Guang-Ping Qiu, Jie Liu. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular CarcinomaGenetic Testing and Molecular Biomarkers 2016; 20(10): 579 doi: 10.1089/gtmb.2016.0073
44
Yang An, Song Gao, Wen-Chao Zhao, Bao-An Qiu, Nian-Xin Xia, Peng-Jun Zhang, Zhen-Ping Fan. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(24): 2596-2604 doi: 10.3748/wjg.v24.i24.2596